Connect with us

Health

Who Should Be Allowed a Medically Assisted Death?

Published

on

Who Should Be Allowed a Medically Assisted Death?
Advertisement

Ron Curtis, an English professor in Montreal, lived for 40 years with a degenerative spinal disease, in what he called the “black hole” of chronic pain.

On a July day in 2022, Mr. Curtis, 64, ate a last bowl of vegetable soup made by his wife, Lori, and, with the help of a palliative care doctor, died in his bedroom overlooking a lake.

Advertisement

Aron Wade, a successful 54-year-old stage and television actor in Belgium, decided he could no longer tolerate life with the depression that haunted him for three decades.

Last year, after a panel of medical experts found he had “unbearable mental suffering,” a doctor came to his home and gave him medicine to stop his heart, with his partner and two best friends at his side.

Argemiro Ariza was in his early 80s when he began to lose function in his limbs, no longer able to care for his wife, who had dementia, in their home in Bogotá.

Advertisement

Doctors diagnosed A.L.S., and he told his daughter Olga that he wanted to die while he still had dignity. His children threw him a party with a mariachi band and lifted him from his wheelchair to dance. A few days later, he admitted himself to a hospital, and a doctor administered a drug that ended his life.

Until recently, each of these deaths would have been considered a murder. But a monumental change is underway around the world. From liberal European countries to conservative Latin American ones, a new way of thinking about death is starting to take hold.

Advertisement

Over the past five years, the practice of allowing a physician to help severely ill patients end their lives with medication has been legalized in nine countries on three continents. Courts or legislatures, or both, are considering legalization in a half-dozen more, including South Korea and South Africa, as well as eight of the 31 American states where it remains prohibited.

It is a last frontier in the expansion of individual autonomy. More people are seeking to define the terms of their deaths in the same way they have other aspects of their lives, such as marriage and childbearing. This is true even in Latin America, where conservative institutions such as the Roman Catholic church are still powerful.

“We believe in the priority of our control over our bodies, and as a heterogeneous culture, we believe in choices: If your choice does not affect me, go ahead,” said Dr. Julieta Moreno Molina, a bioethicist who has advised Colombia’s Ministry of Health on its assisted dying regulations.

Advertisement

Yet, as assisted death gains more acceptance, there are major unresolved questions about who should be eligible. While most countries begin with assisted death for terminal illness, which has the most public support, this is often followed quickly by a push for wider access. With that push comes often bitter public debate.

Should someone with intractable depression be allowed an assisted death?

Advertisement

European countries and Colombia all permit people with irremediable suffering from conditions such as depression or schizophrenia to seek an assisted death. But in Canada, the issue has become contentious. Assisted death for people who do not have a reasonably foreseeable natural death was legalized in 2021, but the government has repeatedly excluded people with mental illness. Two of them are challenging the exclusion in court on the grounds that it violates their constitutional rights.

In public debate, supporters of the right to assisted death for these patients say that people who have lived with severe depression for years, and have tried a variety of therapies and medications, should be allowed to decide when they are no longer willing to keep pursuing treatments. Opponents, concerned that mental illness can involve a pathological wish to die, say it can be difficult to predict the potential effectiveness of treatments. And, they argue, people who struggle to get help from an overburdened public health service may simply give up and choose to die, though their conditions might have been improved.

Should a child with an incurable condition be able to choose assisted death?

Advertisement

The ability to consent is a core consideration in requesting assisted death. Only a handful of countries are willing to extend that right to minors. Even in the places that do, there are just a few assisted deaths for children each year, almost always children with cancer.

In Colombia and the Netherlands, children over 12 can request assisted death on their own. Parents can provide consent for children 11 and younger.

Advertisement
Advertisement

Denise de Ruijter took comfort in her Barbie dolls when she struggled to connect with people. She was diagnosed with autism and had episodes of depression and psychosis. As a teenager in a Dutch town, she craved the life her schoolmates had — nights out, boyfriends — but couldn’t manage it.

She attempted suicide several times before applying for an assisted death at 18. Evaluators required her to try three years of additional therapies before agreeing her suffering was unbearable. She died in 2021, with her family and Barbies nearby.

Advertisement

The issue is under renewed scrutiny in the Netherlands, where, over the past decade, a growing number of adolescents have applied for assisted death for relief from irremediable psychiatric suffering from conditions such as eating disorders and anxiety.

Most such applications by teens are either withdrawn by the patient, or rejected by assessors, but public concern over a few high-profile cases of teens who received assisted deaths prompted the country’s regulator to consider a moratorium on approvals for children applying on the basis of psychiatric suffering.

Should someone with dementia be allowed assisted death?

Advertisement

Many people dread the idea of losing their cognitive abilities and their autonomy, and hope to have an assisted death when they reach that point. But this is a more complex situation to regulate than for a person who can still make a clear request.

How can a person who is losing their mental capacity consent to dying? Most governments, and doctors, are too uncomfortable to permit it, even though the idea tends to be popular in countries with aging populations.

Advertisement

In Colombia, Spain, Ecuador and the Canadian province of Quebec, people who have been diagnosed with Alzheimer’s disease or other kinds of cognitive decline can request assessment for an assisted death before they lose mental capacity, sign an advance request — and then have a physician end their life after they have lost the ability to consent themselves.

But that raises a separate, challenging, question: After people lose the capacity to request an assisted death, who should decide it’s time?

Their spouses? Their children? Their doctors? The government? Colombia entrusts families with this role. The Netherlands leaves it up to doctors — but many refuse to do it, unwilling to administer lethal drugs to a patient who can’t clearly articulate a rational wish to die.

Advertisement

Advertisement

Jan Grijpma was always clear with his daughter, Maria: When his mind went, he didn’t want to live any more. Maria worked with his longtime family doctor, in Amsterdam, to identify the point when Mr. Grijpma, 90 and living in a nursing home, was losing his ability to consent himself.

When it seemed close, in 2023, they booked the day, and he updated his day planner: Thursday, visit the vicar; Friday, bicycle with physiotherapy and get a haircut; Sunday, pancakes with Maria; Monday, euthanasia.

Advertisement

All of these questions are becoming part of the discussion as the right to control and plan one’s own death is pushed in front of reluctant legislatures and uneasy medical professionals.

Dr. Madeline Li, a Toronto psychiatrist, was given the task of developing the assisted-dying practice in one of Canada’s largest hospitals when the procedure was first decriminalized in 2015. She began with assessing patients for eligibility and then moved to providing medical assistance in dying, or MAID, as it is called in Canada. For some patients with terminal cancer, it felt like the best form of care she could offer, she said.

Advertisement

But then Canada’s eligibility criteria expanded, and Dr. Li found herself confronting a different kind of patient.

“To provide assisted dying to somebody dying of a condition who is not happy with how they’re going to die, I’m willing to assist them, and hasten that death,” she said. “I struggle more with people who aren’t dying and want MAID — I think then you’re assisting suicide. If you’re not dying — if I didn’t give you MAID, you wouldn’t otherwise die — then you’re a person who’s not unhappy with how you’re going to die. You’re unhappy with how you’re living.”

Who has broken the taboo?

Advertisement

For decades, Switzerland was the only country to permit assisted death; assisted suicide was legalized there in 1942. It took a further half century for a few more countries to loosen their laws. Now decriminalization of some form of assisted death has occurred across Europe.

But there has recently been a wave of legalization in Latin America, where Colombia was long an outlier, having allowed legal assisted dying since 2015.

Advertisement
Advertisement

Paola Roldán Espinosa had a thriving career in business in Ecuador, and a toddler, when she was diagnosed with A.L.S. in 2023. Her health soon deteriorated to the point that she needed a ventilator.

She wanted to die on her terms — and took the case to the country’s highest court. In February 2024, the court responded to her petition by decriminalizing assisted dying. Ms. Roldán, then 42, had the death she sought, with her family around her, a month later.

Advertisement

Ecuador has decriminalized assisted dying through constitutional court cases, and Peru’s Supreme Court has permitted individual exceptions to the law which prohibits the procedure, opening the door to expansion. Cuba’s national assembly legalized assisted dying in 2023, although no regulations on how the procedure will work are yet in place. In October, Uruguay’s parliament passed a long-debated law allowing assisted death for the terminally ill.

The first country in Asia to take steps toward legalization is South Korea, where a bill to decriminalize assisted death has been proposed at the National Assembly several times but has not come to a vote. At the same time, the Constitutional Court, which for years refused to hear cases on the subject, has agreed to adjudicate a petition from a disabled man with severe and chronic pain who seeks an assisted death.

Access in the United States remains limited: 11 jurisdictions (10 states plus the District of Columbia) allow assisted suicide or physician-assisted death, for patients who have a terminal diagnosis, and in some cases, only for patients who are already in hospice care. It will become legal in Delaware on Jan. 1, 2026.

Advertisement

In Slovenia, in 2024, 55 percent of the population who voted in a national referendum were in favor of legalizing assisted death, and parliament duly passed a law in July. But pushback from right-wing politicians then forced a new referendum, and in late November, 54 percent of those who voted rejected the legalization.

And in the United Kingdom, a bill to legalize assisted death for people with terminal illness has made its way slowly through parliament. It has faced fierce opposition from a coalition of more than 60 groups for people with disabilities, who argue they may face subtle coercion to end their lives rather than drain their families or the state of resources for their care.

Advertisement

Why now?

In many countries, decriminalization of assisted dying has followed the expansion of rights for personal choice in other areas, such as the removal of restrictions on same-sex marriage, abortion and sometimes drug use.

“I would expect it to be on the agenda in every liberal democracy,” said Wayne Sumner, a medical ethicist at the University of Toronto who studies the evolution of norms and regulations around assisted dying. “They’ll come to it at their own speed, but it follows with these other policies.”

Advertisement

The change is also being driven by a convergence of political, demographic and cultural trends.

As populations age, and access to health care improves, more people are living longer. Older populations mean more chronic disease, and more people living with compromised health. And they are thinking about death, and what they will — and won’t — be willing to tolerate in the last years of their lives.

Advertisement

At the same time, there is diminishing tolerance for suffering that is perceived as unnecessary.

“Until very recently, we were a society where few people lived past 60 — and now suddenly we live much longer,” said Lina Paola Lara Negrette, a psychologist who until October was the director of the Dying With Dignity Foundation in Colombia. “Now people here need to think about the system, and the services that are available, and what they will want.”

Changes in family structures and communities, particularly in rapidly urbanizing middle-income countries, mean that traditional networks of care are less strong, which shifts how people can imagine living in older age or with chronic illness, she added.

Advertisement

“When you had many siblings and a lot of generations under one roof, the question of care was a family thing,” she said. “That has changed. And it shapes how we think about living, and dying.”

How does assisted dying work?

Advertisement

Beyond the ethical dilemmas, actually carrying out legalized assisted deaths involves countless choices for countries. Spain requires a waiting period of at least 15 days between a patient’s assessments (but the average wait in practice is 75 days). In most other places, the prescribed wait is less than two weeks for patients with terminal conditions, but often longer in practice, said Katrine Del Villar, a professor of constitutional law at the Queensland University of Technology who tracks trends in assisted dying

Most countries allow patients to choose between administering the drugs themselves or having a health care provider do it. When both options are available, the overwhelming majority of people choose to have a health care provider end their life with an injection that stops their heart.

In many countries only a doctor can administer the drugs, but Canada and New Zealand permit nurse practitioners to provide medically assisted deaths too.

Advertisement

One Australian state prohibits medical professionals from raising the topic of assisted death. A patient must ask about it first.

Who determines eligibility is another issue. In the Netherlands, two physicians assess a patient; in Colombia, it’s a panel consisting of a medical specialist, a psychologist and a lawyer. The draft legislation in Britain would require both a panel and two independent physicians.

Advertisement

Switzerland and the states of Oregon and Vermont are the only jurisdictions in the world that explicitly allow people who are not residents access to assisted deaths.

Most countries permit medical professionals to conscientiously object to providing assisted deaths and allow faith-based medical institutions to refuse to participate. In Canada, individual professionals have the right to refuse, but a court challenge is underway seeking to end the ability of hospitals that are controlled by faith-based organizations and that operate with public funds to refuse to allow assisted deaths on their premises.

“Even when assisted dying has been legal and available somewhere for a long time, there can be a gap between what is legal and what is acceptable — what most physicians and patients and families feel comfortable with,” said Dr. Sisco van Veen, an ethicist and psychiatrist at Amsterdam Medical University. “And this isn’t static. It evolves over time.”

Advertisement

Jin Yu Young in Seoul, José Bautista in Madrid, José María León Cabrera in Quito, Veerle Schyns in Amsterdam and Koba Ryckewaert in Brussels contributed reporting.

Health

Common vision issue could lead to missed cancer warning, study finds

Published

on

Common vision issue could lead to missed cancer warning, study finds

NEWYou can now listen to Fox News articles!

Colorblindness, a condition that mostly affects men, could be linked to a higher mortality risk in bladder cancer cases, a new study suggests.

About 8% of men are estimated to have a form of color vision deficiency (CVD), compared to 0.5% of women, according to global statistics.

The condition, in which patients see and identify color differently, could cause people to miss blood in their urine, which is a vital sign of bladder cancer.

RISK OF DEADLY CANCER TRIPLES WITH HIDDEN MOUTH BACTERIA, STUDY FINDS

Advertisement

Blood in the urine is the most common first sign of the disease and is often the impetus that leads to diagnosis, according to researchers at Stanford Medicine.

Those with colorblindness usually have difficulty seeing the colors red and green, which can present “everyday challenges.”

Colorblind bladder cancer patients have a 52% higher mortality risk, a Stanford study finds. (iStock)

In the latest study, published in the journal Nature Health, researchers analyzed health records and found that bladder cancer patients who are also colorblind have a 52% higher mortality rate over 20 years than those patients with normal vision.

Since colorblind people fail to recognize blood in their urine, they may be delayed in seeking care, which can lead to worse outcomes, the findings suggest. Bladder cancer is about four times more common among men than women.

Advertisement

COMMON VITAMIN SHOWN TO SLASH SKIN CANCER RISK IN SOME GROUPS, STUDY SUGGESTS

Senior study author Ehsan Rahimy, M.D., adjunct clinical associate professor of ophthalmology at Stanford Medicine, commented in a press release that he’s “hopeful this study raises some awareness, not only for patients with colorblindness, but for our colleagues who see these patients.”

“Colorblindness doesn’t cause bladder cancer, but it may make the earliest warning sign easier to miss.”

Dr. Douglas Lazzaro, a professor in NYU Langone’s Department of Ophthalmology, said the inability to recognize the color red in this scenario is a “real risk.”

“The patient, family and medical doctor should be made aware of this potential gap in diagnosis,” Lazzaro, who was not involved in the study, told Fox News Digital. “It is important to raise awareness of potential issues in making the diagnosis of bladder or kidney cancer in colorblind individuals.”

Advertisement

A graphic to test colorblindness is shown. Red-green colorblindness is the most common form. (iStock)

“My guess is that many doctors may not be looking closely enough at the medical record to pick up on this eye problem, leading to delays in diagnosis as the patient may not be able to see the issue,” he added.

While the issue may not be completely avoidable, Lazzaro suggested that it could be prevented if colorblind patients are aware of the risk and inform their doctors of their vision limitation.

CLICK HERE FOR MORE HEALTH STORIES

Dr. Don Railsback, optometrist and CEO of Vision Care Direct in Kansas, agreed that people with known CVD and their clinicians should “pay close attention.”

Advertisement

“This is the kind of small detail in a medical history that can change how we counsel patients on the symptoms they should never ignore,” he told Fox News Digital.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“The takeaway is simple: Don’t rely on color alone to detect a problem. Bladder cancer can present as painless bleeding, and if you ever suspect blood in your urine, you should alert your doctor.”

One doctor said this study is a reminder to tailor health guidance to “real-world differences” that are often seen as “small details.” (iStock)

Railsback, who was not part of the research, added that if the color of urine looks “off” — for example, is tea-colored or unusually dark — the patient should be checked “promptly.”

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“This study is a strong reminder to tailor health guidance to real-world differences and variations, including color vision,” he said.

For colorblind individuals, Railsback recommends asking their primary care physician for a urine test at annual visits. If something seems unusual, they should ask a spouse or partner.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“Colorblindness doesn’t cause bladder cancer, but it may make the earliest warning sign easier to miss,” he said. “The fix is awareness and simple testing, not fear.”

Advertisement

Fox News Digital reached out to the study authors for comment.

Continue Reading

Health

Are peptides the fountain of youth? Doctors warn hype may outpace science

Published

on

Are peptides the fountain of youth? Doctors warn hype may outpace science

NEWYou can now listen to Fox News articles!

Peptide therapy has gained popularity as a potential health and longevity booster, but experts are warning of cautions and limitations.

Peptides are short chains of amino acids that act as messengers involved in processes like metabolism, growth and immune function, according to Cleveland Clinic.

Some peptides have shown potential in helping with skin health, metabolism, muscle recovery and immunity, although research is limited, experts say.

OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU

Advertisement

“‘Peptides’ is a broad umbrella that includes everything from well-studied, FDA-approved therapies to experimental compounds marketed for anti-aging with limited human data,” Dr. Brad Younggren, a board-certified physician and CEO and co-founder of Circulate Health in Seattle, Washington, told Fox News Digital.

Injectable GLP-1 diabetes and weight-loss drugs are a common form of peptides, he noted.

Peptides are short chains of amino acids that act as messengers involved in processes like metabolism, growth and immune function. (iStock)

“Most people now more widely understand the positive impact this peptide can have on human healthspan,” Younggren said. “Peptides have broad targets across human physiology, and each one must be explored independently.”

Other common types of peptides help with growth hormone production, healing and tissue repair, skin and hair health, immune regulation, and cardiovascular and blood pressure regulation.

Advertisement

Are peptides the fountain of youth?

Despite some claims of peptides extending lifespan, Younggren cautioned that no longevity therapy or treatment should be considered a “fountain of youth.”

“The science is promising in specific areas, but the category as a whole is not a single, proven longevity solution,” he said. “Peptides may be useful tools in select clinical contexts, but claims of universal rejuvenation are ahead of the evidence.”

JELLY ROLL’S WIFE SAYS WEIGHT-LOSS DRUG SENT HER INTO ‘WORST SUICIDAL DEPRESSION’

Ben Perez, the biomedical technology specialist at Pure Tested Peptides in Pennsylvania, noted that some people have seen benefits in recovery, immunity and tissue repair, while others have reported positive outcomes related to sleep, lean body mass and recovery time.

However, while peptides show promise, he said some suggested results may be “overly optimistic.”

Advertisement

Despite some claims of peptides extending lifespan, one expert cautioned that no longevity therapy or treatment should be considered a “fountain of youth.” (iStock)

“Some are anti-aging related and assist with cellular repair, release of growth hormones and metabolic functions,” Perez, who oversees quality control of research peptides, told Fox News Digital. “However, the results can be inconsistent, and the assertions are usually greater than the supportive research.”

Side effects

Each type of peptide can be associated with its own potential side effects, experts say.

Growth hormone–related therapies, particularly those that act on the growth hormone (GH)–IGF-1 axis, can affect multiple hormone pathways and carry risks such as fluid retention, insulin resistance, headaches and joint symptoms, as well as changes in blood pressure or lipid levels, according to Dr. Anant Vinjamoori, M.D., a Harvard-trained physician and chief longevity officer at Superpower.

6 LONGEVITY RULES EXPERTS FOLLOW FOR HEALTHIER AGING IN 2026

Advertisement

“The pathways in the study of peptides are complex and can lead to imbalances in the hormones of the body,” Perez said. “Other negative outcomes can be localized inflammation at the injection site and other reactions.”

“Endocrine disorders, autoimmune disorders and history of cancer are further reasons to be more careful.”

“Selling unproven, miracle-promising or supplement-peddling products with little accountability or third-party testing is a dangerous red flag.”

The most reliable way to receive peptide therapy is through injection, according to Vinjamoori, as some oral forms can be “under-absorbed” or may rely on added ingredients that can cause side effects.

“‘Safe’ is less about the route and more about the molecule, dose, purity and monitoring,” he told Fox News Digital.

Advertisement

“Most peptides have an extremely strong track safety record based on the data we do have — but there is still much that we do not know.”

Approval and regulation

Some peptides are FDA-approved for specific conditions, including GLP-1s and growth-hormone stimulators. These may be prescribed off-label in some contexts, although risks and benefits vary and evidence may be limited, according to experts.

CLICK HERE FOR MORE HEALTH STORIES

There are also some peptides that are not FDA-approved. “Many ‘fitness’ peptides discussed online are in early clinical phases or used only in research settings,” Vinjamoori noted.

“[Peptides] should be approached as a combination of lifestyle measures that contribute to better healthspan,” one expert said. (iStock)

Advertisement

Perez warned that peptides have little to no regulation in many countries, which means online vendors may sell fake, poor-quality or dangerous products. 

“Selling unproven, miracle-promising or supplement-peddling products with little accountability or third-party testing is a dangerous red flag,” he said.

Starting safely

For those considering peptides, Vinjamoori recommends watching out for the following red flags.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

  • Sourcing issues: Non-pharmacy “research chemicals,” lack of third-party testing or unclear labeling
  • Overblown claims: Promises of rapid muscle gain or fat loss with no training changes
  • Too many compounds: Stacking multiple substances without clear targets or bloodwork
  • Lack of oversight: No clinician, baseline labs, or plan for cycling or stopping

“The most effective longevity care is proactive, personalized, and grounded in biomarkers and scientific evidence,” Younggren added. “It should be approached as a combination of lifestyle measures that contribute to better healthspan.”

Anyone interested in peptides should consult a physician to ensure that they receive a safe product and that it is used appropriately. (iStock)

Advertisement

Perez emphasized the importance of starting conservatively. “Understand the science, know the source and get medical guidance,” he advised. “Peptide therapy isn’t one-size-fits-all; it’s nuanced and still evolving.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

While peptides may address issues that fall outside the reach of conventional medicine, Perez said, the supporting clinical data is still being developed.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“Excessive use can lead to a decrease in their therapeutic effects and may cause adverse reactions, so more is not necessarily better,” he cautioned.

Advertisement

Anyone interested in peptides should consult with a physician to ensure that they receive a safe product and that it is used appropriately.

Continue Reading

Health

Which ‘Appetite Type’ Are You? It Could Be the Key To Not Overeating

Published

on

Which ‘Appetite Type’ Are You? It Could Be the Key To Not Overeating


Advertisement




Learn How To Stop Overeating by Identifying Your ‘Appetite Type’ | Woman’s World




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading
Advertisement

Trending